Aurora Cannabis has received an unsolicited takeover proposal from Curaleaf offering $4 per share, combining cash and Curaleaf shares. Aurora's board is reviewing the offer carefully, noting the price is lower than past trading values and emphasizing their ongoing strategic plans, including recent acquisitions and expansion in Europe. Aurora has not made any decision and will form a special committee to evaluate the proposal while continuing normal operations. Shareholders are advised no action is needed currently, and further comments will depend on future developments or legal requirements.
Aurora Cannabis has named Faris El Refaie as Executive Vice President, Global Commercial, starting September 28, 2026. This new role aims to enhance Aurora's medical cannabis market strategy and expand its presence across Canada, Europe, Australia, N...
Curaleaf Holdings has released a detailed fact sheet countering Aurora Cannabis's criticisms of its $5 billion acquisition proposal. Curaleaf argues its offer includes one of the highest premiums in Canadian M&A history and highlights Aurora's poor f...
